Chronic Diseases

Diabetes Obesity Diabetes Management Respiratory Diseases Obesity Management Type 2 Diabetes Diabetes Care Obesity Treatment Diabetes Treatment Cardiovascular Health Cardiovascular Diseases Non-communicable Diseases Obesity-Related Conditions Hepatitis C Preventive Medicine Patient Care Medical Misinformation Management COPD Cancer Prevention Gynecological Disorders Renal Diseases Ageing Population Liver Fibrosis Obesity-Related Diseases Neurology Inflammatory Diseases Sickle Cell Disease Childhood Obesity Kidney Diseases Risk Predictions Alzheimer's Disease Specialty Pharmacies Diabetes Mellitus Demographics Treatment Options Autoimmune Conditions Hypertension Metabolic Disorders

AI Liquid Biopsy Reads cfDNA Fragmentome to Detect Early Liver Fibrosis and Cirrhosis

Machine learning on genome-wide cfDNA fragmentation provides a noninvasive readout of liver damage often missed by standard blood tests.

GLP-1 Drugs Plus Healthy Habits Linked to Lower Heart Risk in Large VA Diabetes Study

RFK Jr.’s ‘Sickest People’ Claim Triggers High-Profile Pushback as Reiner Cites Vaccine Policy Turmoil

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

ABIVAX to Present Late-Breaking Phase 3 Ulcerative Colitis Data on Oct. 6 at UEG Congress

Monthly Phone Coaching Sustains Weight Loss for 20 Months as Algorithmic Extra Calls Fall Short

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

Global Study Finds Nearly Half of People With Diabetes Go Undiagnosed

Review Finds COPD Risk Elevated in People With Schizophrenia, Even After Smoking Adjustment

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health